FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1629-1631 November 26, 1998 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Furlan, M. Related Article by Tsai, H.-M. PubMed Citation

In 1924, Dr. Eli Moschcowitz described the abrupt onset of petechiae and pallor, followed rapidly by paralysis, coma, and death, in a 16-year-old girl.¹ Terminal arterioles and capillaries in the doomed teenager were occluded by hyaline thrombi, later determined to consist mostly of platelets without perivascular inflammation or endothelial desquamation. Moschcowitz suspected a "powerful poison which had both agglutinative and hemolytic properties"¹ as the cause of this frightening new disease, now known as thrombotic thrombocytopenic purpura.

In 1982, unusually large multimers of von Willebrand factor found in the plasma of patients with chronic relapsing thrombotic thrombocytopenic purpura were proposed as . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Izzedine, H., Isnard-Bagnis, C., Launay-Vacher, V., Mercadal, L., Tostivint, I., Rixe, O., Brocheriou, I., Bourry, E., Karie, S., Saeb, S., Casimir, N., Billemont, B., Deray, G. (2006). Gemcitabine-induced thrombotic microangiopathy: a systematic review. Nephrol Dial Transplant 21: 3038-3045 [Full Text]  
• Lewis, E J, Schwartz, M M (2005). Pathology of lupus nephritis. Lupus 14: 31-38 [Abstract]  
• Remuzzi, G., Galbusera, M., Noris, M., Canciani, M. T., Daina, E., Bresin, E., Contaretti, S., Caprioli, J., Gamba, S., Ruggenenti, P., Perico, N., Mannucci, P. M. (2002). von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood 100: 778-785 [Abstract] [Full Text]  
• DREWS, R. E., WEINBERGER, S. E. (2000). Thrombocytopenic Disorders in Critically Ill Patients. Am. J. Respir. Crit. Care Med. 162: 347-351 [Full Text]  
• Bennett, C. L., Connors, J. M., Carwile, J. M., Moake, J. L., Bell, W. R., Tarantolo, S. R., McCarthy, L. J., Sarode, R., Hatfield, A. J., Feldman, M. D., Davidson, C. J., Tsai, H.-M. (2000). Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel. NEJM 342: 1773-1777 [Abstract] [Full Text]  
• Hayden, G. F (1999). Alliteration in medicine: a puzzling profusion of p's. BMJ 319: 1605-1608 [Abstract] [Full Text]  
• Galbusera, M., Noris, M., Rossi, C., Orisio, S., Caprioli, J., Ruggeri, Z. M., Amadei, B., Ruggenenti, P., Vasile, B., Casari, G., Remuzzi, G. (1999). Increased Fragmentation of von Willebrand Factor, Due to Abnormal Cleavage of the Subunit, Parallels Disease Activity in Recurrent Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura and Discloses Predisposition in Families. Blood 94: 610-620 [Abstract] [Full Text]